Srivastava; Ankita
Patent Applications and Registrations
Patent applications and USPTO patent grants for Srivastava; Ankita.The latest application filed is for "progranulin variants".
- Srivastava; Ankita - South San Francisco CA
- SRIVASTAVA; Ankita - Mumbai IN
| Patent | Date |
|---|---|
| Progranulin Variants App 20220220172 - Cherf; Gerald Maxwell ; et al. | 2022-07-14 |
| Progranulin Variants App 20220213155 - Cherf; Gerald Maxwell ; et al. | 2022-07-07 |
| Anti-trem2 Antibodies And Methods Of Use Thereof App 20220119522 - Dennis; Mark S. ; et al. | 2022-04-21 |
| Anti-trem2 Antibodies And Methods Of Use Thereof App 20220073609 - Dennis; Mark S. ; et al. | 2022-03-10 |
| Pharmaceutical Combination For The Treatment Of Melanoma App 20210393589 - AGARWAL; Veena ; et al. | 2021-12-23 |
| Fusion Proteins Comprising Progranulin App 20210284702 - Di Paolo; Gilbert ; et al. | 2021-09-16 |
| Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes App 20210198640 - Astarita; Giuseppe ; et al. | 2021-07-01 |
| Progranulin Variants App 20210188925 - Cherf; Gerald Maxwell ; et al. | 2021-06-24 |
| Pharmaceutical combination for the treatment of melanoma Grant 11,007,174 - Agarwal , et al. May 18, 2 | 2021-05-18 |
| Fusion proteins comprising enzyme replacement therapy enzymes Grant 10,870,837 - Henry , et al. December 22, 2 | 2020-12-22 |
| Engineered Transferrin Receptor Binding Polypeptides App 20200369746 - Chen; Xiaocheng ; et al. | 2020-11-26 |
| Anti-trem2 Antibodies And Methods Of Use Thereof App 20200277373 - Chen; Hang ; et al. | 2020-09-03 |
| Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes App 20200277584 - ASTARITA; Giuseppe ; et al. | 2020-09-03 |
| Engineered Transferrin Receptor Binding Polypeptides App 20200223935 - Chen; Xiaocheng ; et al. | 2020-07-16 |
| Pharmaceutical Combination For The Treatment Of Melanoma App 20190282544 - AGARWAL; Veena ; et al. | 2019-09-19 |
| Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes App 20190249155 - Henry; Anastasia ; et al. | 2019-08-15 |
| A Pharmaceutical Combination For The Treatment Of Melanoma App 20160136132 - AGARWAL; Veena ; et al. | 2016-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 